Delivery Order SPE2DB22D3016-SPE2DB25FBDV7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of VYVGART 400 mg/20 ml vials totaling $12,792.51 with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $38,377.53 to AmerisourceBergen Drug Corp for the supply of VYVGART 400 mg/20 mL vials on July 28, 2025, with a completion date of August 18, 2025. This firm fixed-price contract, which received no set-aside designation, was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,528.34 to AmerisourceBergen Drug Corp for VYVGART 400 MG/20 ML vials (20 ML). This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 25, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through...
- This is a $12,792.51 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML, with an ultimate completion date of July 1, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $48,621.84 to provide VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. This contract has a completion date of March 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award. This delivery order contract is issued under a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp., a major pharmaceutical distribution company, a delivery order contract worth $35,965.17 for the supply of 400 mg/20 ml vials of the medication VYVGART. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a potential value of $8,103.66 and a completion date of March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to...
- This is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a ceiling value of $8,103.66 and an ultimate completion date of October 4, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans' hospitals. This award is part of a larger...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a prescription medication, with a ceiling value of $38,377.53 and a performance period through July 8, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $8,103.66 firm-fixed-price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a specialized pharmaceutical product. The contract does not have a set-aside designation and has an ultimate completion date of September 25, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDV7Delivery Order
The Defense Logistics Agency awarded a $34,113.36 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of VYVGART 400 mg/20 mL vials. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The VYVGART supply under this delivery order supports DLA's medical supply chain operations and the broader Defense Health Agency mission to provision pharmaceuticals to military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.1k | 8/4/25 |